These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38351812)
1. Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status. Tashkova D; Ilieva N; Serteva D; Feodorova Y; Mehterov N; Mollova A; Bachurska S Folia Med (Plovdiv); 2023 Jun; 65(3):378-383. PubMed ID: 38351812 [TBL] [Abstract][Full Text] [Related]
2. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Lugli A; Tzankov A; Zlobec I; Terracciano LM Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323 [TBL] [Abstract][Full Text] [Related]
3. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779 [TBL] [Abstract][Full Text] [Related]
4. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition. Gurzu S; Szentirmay Z; Toth E; Bara T; Bara T; Jung I PLoS One; 2013; 8(3):e57699. PubMed ID: 23469219 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of CK20, CK7, and CDX2 in colorectal carcinoma in correlation with pathomorphological characteristics. Ilieva N; Tashkova D; Staykov D; Serteva D; Feodorova Y; Mehterov N; Mollova A; Bachurska S Folia Med (Plovdiv); 2022 Apr; 64(2):214-220. PubMed ID: 35851772 [TBL] [Abstract][Full Text] [Related]
6. Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia. Aissi S; Buisine MP; Zerimech F; Kourda N; Moussa A; Manai M; Porchet N World J Gastroenterol; 2013 Aug; 19(32):5286-94. PubMed ID: 23983431 [TBL] [Abstract][Full Text] [Related]
7. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations. Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813 [TBL] [Abstract][Full Text] [Related]
8. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages. Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517 [TBL] [Abstract][Full Text] [Related]
9. Loss of SATB2 Expression in Colorectal Carcinoma Is Associated With DNA Mismatch Repair Protein Deficiency and BRAF Mutation. Ma C; Olevian DC; Lowenthal BM; Jayachandran P; Kozak MM; Chang DT; Pai RK Am J Surg Pathol; 2018 Oct; 42(10):1409-1417. PubMed ID: 30001238 [TBL] [Abstract][Full Text] [Related]
10. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival. Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419 [TBL] [Abstract][Full Text] [Related]
11. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency. Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180 [TBL] [Abstract][Full Text] [Related]
12. Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer. Li J; Zeng Q; Lin J; Huang H; Chen L Med Mol Morphol; 2024 Mar; 57(1):1-10. PubMed ID: 37583001 [TBL] [Abstract][Full Text] [Related]
13. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression. Landau MS; Kuan SF; Chiosea S; Pai RK Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142 [TBL] [Abstract][Full Text] [Related]
14. Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features. Rosty C; Young JP; Walsh MD; Clendenning M; Walters RJ; Pearson S; Pavluk E; Nagler B; Pakenas D; Jass JR; Jenkins MA; Win AK; Southey MC; Parry S; Hopper JL; Giles GG; Williamson E; English DR; Buchanan DD Mod Pathol; 2013 Jun; 26(6):825-34. PubMed ID: 23348904 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency. Nakano K; Yamamoto H; Fujiwara M; Koga Y; Tsuruta S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y Am J Surg Pathol; 2018 Feb; 42(2):172-182. PubMed ID: 28877066 [TBL] [Abstract][Full Text] [Related]
16. Mutational status of KRAS and MMR genes in a series of colorectal carcinoma cases. Cionca FL; Dobre M; Dobrea CM; Iosif CI; Comănescu MV; Ardeleanu CM Rom J Morphol Embryol; 2018; 59(1):121-129. PubMed ID: 29940619 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS. Wang J; Yi Y; Xiao Y; Dong L; Liang L; Teng L; Ying JM; Lu T; Liu Y; Guan Y; Pang J; Zhou L; Lu J; Zhang Z; Liu X; Liang X; Zeng X; Yi X; Zhou W; Xia X; Yang L; Zhang J; Kopetz S; Futreal PA; Wu H; Liang Z Mod Pathol; 2019 Jul; 32(7):1053-1064. PubMed ID: 30723297 [TBL] [Abstract][Full Text] [Related]
18. Unique clinicopathologic and genetic alteration features in early onset colorectal carcinoma compared with age-related colorectal carcinoma: a large cohort next generation sequence analysis. Escobar D; Jones R; Gao J; Sun L; Liao J; Yang GY Hum Pathol; 2020 Nov; 105():37-46. PubMed ID: 32916163 [TBL] [Abstract][Full Text] [Related]
19. Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions. Cocco E; Benhamida J; Middha S; Zehir A; Mullaney K; Shia J; Yaeger R; Zhang L; Wong D; Villafania L; Nafa K; Scaltriti M; Drilon A; Saltz L; Schram AM; Stadler ZK; Hyman DM; Benayed R; Ladanyi M; Hechtman JF Cancer Res; 2019 Mar; 79(6):1047-1053. PubMed ID: 30643016 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors. Bae JM; Cho NY; Kim TY; Kang GH Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]